Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

20.36 +1.53 (+8.13%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health Inc

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Can the New CEO Revive This Struggling Telehealth Stock?
Virtual healthcare provider Teladoc Health Inc. (NYSE: TDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023 
Via MarketBeat
Topics Earnings
Exposures Financial
3 Once-in-a-Lifetime Stock Opportunities You Can’t Miss: July 2024
Discover three high-potential stocks in the tech, financial and healthcare sectors that can deliver significant returns. 
Via InvestorPlace
What's Going On With Hims & Hers Shares Today?
Hims & Hers Health, Inc. (NYSE: HIMS) saw a notable surge in its stock Tuesday possibly from continued momentum from yesterday. Here's what you need to know. 
Via Benzinga
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Analyst Scoreboard: 9 Ratings For Hims & Hers Health
Via Benzinga
Peering Into Hims & Hers Health's Recent Short Interest
Via Benzinga
Hims & Hers Stock Drops 12.8% After Short Report
Is this a warning or a buy sign for Hims & Hers stock? 
Via The Motley Fool
Why Hims & Hers Heath Shares Are Surging Today
Hims & Hers Health Inc. (NYSE: HIMS) shares are moving higher on Monday amidst the announcement of Kåre Schultz's appointment to the Board of Directors. 
Via Benzinga
Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
From Hims & Hers
Via Business Wire
Here's My Top Growth Stock to Buy Right Now
Hims & Hers shares have multi-bagger growth potential over the years to come. 
Via The Motley Fool
Is This Telehealth Stock a Buy After the Recent Pullback?
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions. 
Via MarketBeat
Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024
From Hims & Hers
Via Business Wire
3 Stocks Poised to 10X in the Next 5 Years
Explore the potential 10X stocks that could revolutionize the investment strategy in the healthcare and consumer discretionary sectors. 
Via InvestorPlace
2 Incredibly Cheap Growth Stocks to Buy Now
Price is just one factor to consider. 
Via The Motley Fool
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
Via Benzinga
3 Companies Set To Positively Surprise This Earnings Season
The period looks to be positive, with earnings growth expected to be strong, again underpinned by a strong forecasted showing from the Tech sector. But how do expectations stack up heading into the... 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Stocks That Can Double Again in 2024
It wasn't easy to double in 2024, but these three stocks made it happen. They might be able to do it again. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Is Hims & Hers Stock a Buy After Short Report?
There are valid points in the short report, but it may present a buying opportunity for long-term investors. 
Via The Motley Fool
Phunware (PHUN) Stock Volatile Ahead of Trump-Biden Debate Tonight
Phunware stock is on the move Thursday as investors in PHUN shares prepare for Donald Trump to debate Joe Biden tonight. 
Via InvestorPlace
Topics Government
Exposures Political
Walgreens Stores Closing: Retailer Announces ‘Imminent’ Changes as WBA Stock Slumps
Walgreens stores will be closing as the company's CEO announces that changes need to happen at the struggling pharmacy chain. 
Via InvestorPlace
Hims & Hers Health Stock Is Sliding Thursday: What's Going On?
Hunterbrook releases a bearish report alleging that Hims & Hers sells knockoff GLP-1 weight loss drugs and relies on a single supplier with previously unreported ties to fraud and bankruptcy. 
Via Benzinga
Topics Fraud Supply Chain
Exposures Legal Supply Chain
Short Seller Hunterbrook Slams Hims & Hers (HIMS) Stock in New Report
HIMS stock is trading lower after Hunterbrook Media published a short report on the company, taking issue with its compounded GLP-1 drug. 
Via InvestorPlace
Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
2 Top Growth Stocks to Buy With $500 Right Now
These top stocks have roaring growth stories to follow. 
Via The Motley Fool
Why Hims Is a 10x Stock
Disrupting the medical industry has enormous upside. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Should You Buy Hims & Hers Health Stock Right Now?
The telehealth company is offering innovative products at lower prices. 
Via The Motley Fool
Pre-Market Movers - June 21, 2024
Sarepta jumps after announcing expanded approval of DMD drug and more news on today's top movers. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.